Programmable helmet system for photobiomodulation

This helmet for transcranial photobiomodulation represents another technical advance in the field of transcranial PBM. It allows deeper penetration of infrared light, enabling greater influence on changes in cellular activity.

Photobiomodulation (PBM) offers exciting possibilities for improving the lives of people with a wide variety of brain disorders.
 In recent years, PBM has been used to treat a range of brain disorders, including stroke, global ischemia, and traumatic brain injury; neurodegenerative diseases such as dementia, Alzheimer's, and Parkinson's; and neuropsychiatric disorders such as major depression, bipolar disorder, anxiety, and post-traumatic stress disorder.

Studies suggest that PBM is an effective strategy for promoting microcirculation and cell proliferation and regeneration, as well as reducing pain, edema, oxidative stress, and inflammation in many traumatic, acute, and chronic conditions. There is increasing interest in using it as a strategy to improve performance in healthy young and older people (peak performance training)
There is growing preclinical evidence to support the hypothesis that PBM may reduce neuronal oxidative stress, neuroinflammation, and apoptosis (cell death) and stimulate neurogenesis and synaptogenesis.

Prof. Dr. Michael Hamblin one of the leading researchers in this field comments:
"PBM therapy of the brain is a promising method in which red to near-infrared light emitted by lasers or light-emitting diodes (LEDs) is delivered to the scalp to stimulate neurons and brain function."
It has been shown to increase cerebral blood flow and also increase cerebral metabolic capacity. Nowadays, the applications of PBM therapy in modern medicine are extremely diverse, so it has gained considerable credibility among the available therapeutic strategies."